Trial intelligence / Profile preview

Vitamin D3 Supplementation in Young Adults vs Seniors

2024-511889-36-01Phase 3Withdrawn

Sponsor
Fakultní nemocnice Plzeň
Start
Oct 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Fakultní nemocnice Plzeň. Primary endpoint: Serum 25-hydroxycholecalciferol level. Planned start Oct 2024; status: withdrawn.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on 2024-511889-36-01.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-511889-36-01.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call